News Releases

Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology

December 1, 2020

Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine

November 23, 2020

Anixa Biosciences to Host Conference Call to Provide Update on Programs

October 27, 2020

Anixa Biosciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference

September 8, 2020

Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds

August 13, 2020

Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission

July 28, 2020

Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders

July 20, 2020

Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office

July 10, 2020

Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds

July 6, 2020

Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline

July 2, 2020

1
2
3
4
5
6
7
8
9
10
...16
Next »

Latest News & Events

Dec 1, 2020

Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology

Read More...

Nov 23, 2020

Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine

Read More...

Oct 27, 2020

Anixa Biosciences to Host Conference Call to Provide Update on Programs

Read More...